Combined erbB/VEGFR blockade has improved anticancer activity over single-pathway inhibition in ovarian cancer in vivo
Year: 2011
Type: article
Source: Gynecologic Oncology
Authors: T. Farzan, S. Harrington, J. Krempski, S. Weroha, X. Hou, K. Kalli, P. Haluska
Institution: Mayo Clinic
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2070509111
